Professur für Molekulare Mechanismen der Organfibrose

Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study (2017) Hsu VM, Denton CP, Domsic RT, Furst DE, Rischmueller M, Stanislav M, Steen VD, et al. Journal article Type 2 Innate Lymphoid Cells - Cellular Source of Profibrotic Mediators Rapidly and Persistently Recruited in Experimental Fibrosis and Systemic Sclerosis (2016) Weber S, Wohlfahrt T, Rauber S, Luber M, Englbrecht M, Dees C, Beyer C, et al. Conference contribution THE INVOLVEMENT OF THE LONG NONCODING H19X IN TGF beta SIGNALING AND ITS PROFIBROTIC EFFECTS IN SYSTEMIC SCLEROSIS AND OTHER FIBROTIC DISEASES (2016) Pachera E, Assassi S, Salazar G, Frank-Bertoncelj M, Dobrota R, Brock M, Kurreeman F, et al. Conference contribution THE SEROTONIN RECEPTOR 2 INHIBITOR TERGURIDE HAS BENEFICIAL EFFECTS ON SKIN FIBROSIS: RESULTS FROM A PHASE 2 PROOF OF CONCEPT STUDY (2016) Distler O, Maurer B, Vettori S, Blumhardt S, Frey D, Distler A, Beyer C, Distler J Conference contribution Variable effects of different serotonin receptor subtype antagonists on the development of transplant vasculopathy in murine aortic allografts (2016) Heim C, Gocht A, Distler J, Spriewald B, Ramsperger-Gleixner M, Weyand M, Ensminger SM Conference contribution Jumonji Domain Containing Protein 3 (JMJD3) As a Novel Epigenetic Mechanism of Fibroblast Activation By Regulation of Fra-2 (2016) Bergmann C, Brandt A, Dees C, Zhang Y, Lin NY, Chen CW, Mallano T, et al. Conference contribution OBSERVATIONAL STUDY OF OUTCOME IN PATIENTS WITH EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS TREATED WITH IMMUNOSUPPRESSIVE THERAPIES (ESOS STUDY) (2016) Herrick AL, Pan X, Peytrignet S, Hesselstrand R, Mouthon L, Brown E, Czirjak L, et al. Conference contribution INFLUENCE OF SEROTONIN (5-HT) RECEPTOR TYPE 2 ANTAGONISTS ON THE DEVELOPMENT OF TRANSPLANT VASCULOPATHY IN A MODEL OF MURINE AORTIC TRANSPLANTATION (2016) Gocht A, Distler J, Ensminger S, Spriewald B, Ramsperger-Gleixner M, Weyand M, Heim C Conference contribution Fibroblast Growth Factor 9/Fibroblast Growth Factor Receptor 3 Signaling Is Upstream of Several Profibrotic Pathways and Induces Fibroblast Activation and Tissue Fibrosis in SSc (2016) Mallano T, Distler A, Dees C, Huang J, Distler O, Schett G, Distler J, Chakraborty D Conference contribution FRA2 IS PLAYING A KEY ROLE IN THE CONTROL OF TREG DEVELOPMENT AND AUTOIMMUNITY (2016) Renoux F, Stellato M, Pachera E, Impellizzieri D, Dees C, Distler J, Kania G, et al. Conference contribution